Fourteen-year (1987 to 2000) trends in the attack rates of, therapy for, and mortality from non-ST-elevation acute coronary syndromes in four United States communities

American Journal of Cardiology

Volumn 96, Issue 10, 2005, Pages 1349-1355

  Watkins, Stanley ^a   Thiemann, David ^a   Coresh, Josef ^a   Powe, Neil ^a   Folsom, Aaron R ^b   Rosamond, Wayne ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMMUNITY CARE; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; MEDICAL PRACTICE; MORTALITY; PREDICTION; PRIORITY JOURNAL; ST SEGMENT ELEVATION; SURVIVAL;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ASPIRIN; CORONARY ANGIOGRAPHY; CORONARY CARE UNITS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PATIENT ADMISSION; POPULATION SURVEILLANCE; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 27644530457     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.037     Document Type: Article

References (26)

1. M.I. Furman, H.L. Dauerman, R.J. Goldberg, J. Yarzebski, D. Lessard, J.M. Gore Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction a multi-hospital, community-wide perspective J Am Coll Cardiol 37 2001 1571 1580
2. S. Savonitto, D. Ardissino, C.B. Granger, G. Morando, M.D. Prando, A. Mafrici, C. Cavallini, G. Melandri, T.D. Thompson, A. Vahanian Prognostic value of the admission electrocardiogram in acute coronary syndromes JAMA 281 1999 707 713
3. M.T. Roe, E.M. Ohman, C.V. Pollack Jr, E.D. Peterson, R.G. Brindis, R.A. Harrington, R.H. Christenson, S.C. Smith Jr, R.M. Califf, W.B. Gibler Changing the model of care for patients with acute coronary syndromes Am Heart J 146 2003 605 612
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 Lancet 2 1988 349 360
5. C.L. Grines, K.F. Browne, J. Marco, D. Rothbaum, G.W. Stone, J. O'Keefe, P. Overlie, B. Donohue, N. Chelliah, G.C. Timmis The Primary Angioplasty in Myocardial Infarction Study Group A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction N Engl J Med 328 1993 673 679
6. A.D. White, A.R. Folsom, L.E. Chambless, A.R. Sharret, K. Yang, D. Conwill, M. Higgins, O.D. Williams, H.A. Tyroler Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study methods and initial two years' experience J Clin Epidemiol 49 1996 223 233
7. R.J. Prineas, R.S. Crow, H.W. Blackburn The Minnesota Code Manual of Electrocardiographic Findings Standards and Procedures for Measurement and Classification 1982 J. Wright Boston
8. D.R. Jacobs Jr, C. Kroenke, R. Crow, M. Deshpande, D.F. Gu, L. Gatewood, H. Blackburn PREDICT: a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey Circulation 100 1999 599 607
9. L. Gordis Epidemiology 2000 W.B. Saunders Philadelphia
10. STATA Version 8. College Station, TX: STATA 2002
11. A. Reikvam, E. Kvan, I. Aursnes Use of cardiovascular drugs after acute myocardial infarction a marked shift towards evidence-based drug therapy Cardiovasc Drugs Ther 16 2002 451 456
12. E.S. Ford, A.H. Mokdad, W.H. Giles, G.A. Mensah Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults findings from the National Health and Nutrition Examination Survey, 1999 to 2000 Circulation 107 2003 2185 2189
13. E.A. Jackson, R. Sivasubramian, F.A. Spencer, J. Yarzebski, D. Lessard, J.M. Gore, R.J. Goldberg Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997) a population-based perspective Am Heart J 144 2002 259 268
14. P.G. McGovern, D.R. Jacobs Jr, E. Shahar, D.K. Arnett, A.R. Folsom, H. Blackburn, R.V. Luepker Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997 the Minnesota heart survey Circulation 104 2001 19 24
15. D.R. Burwen, D.H. Galusha, J.M. Lewis, M.R. Bedinger, M.J. Radford, H.M. Krumholz, J.M. Foody National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999 the medicare health care quality improvement program Arch Intern Med 163 2003 1430 1439
16. C.L. Pashos, S.L. Normand, J.B. Garfinkle, J.P. Newhouse, A.M. Epstein, B.J. McNeil Trends in the use of drug therapies in patients with acute myocardial infarction 1988 to 1992 J Am Coll Cardiol 23 1994 1023 1030
17. R.L. Frye, M.M. Brooks, R.W. Nesto Gap between clinical trials and clinical practice lessons from the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 107 2003 1837 1839
18. H. Tunstall-Pedoe, K. Kuulasmaa, M. Mahonen, H. Tolonen, E. Ruokokoski, P. Amouyel Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547 1557
19. P.G. McGovern, J.S. Pankow, E. Shahar, K.M. Doliszny, A.R. Folsom, H. Blackburn, R.V. Luepker The Minnesota Heart Survey Investigators Recent trends in acute coronary heart disease - mortality, morbidity, medical care, and risk factors N Engl J Med 334 1996 884 890
20. W.D. Rosamond, L.E. Chambless, A.R. Folsom, L.S. Cooper, D.E. Conwill, L. Clegg, C.H. Wang, G. Heiss Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994 N Engl J Med 339 1998 861 867
21. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet Glycoprotein IIb/IIIa in Unstable Angina Receptor Suppression Using Integrilin Therapy N Engl J Med 339 1998 436 443
22. P. Theroux, H. Ouimet, J. McCans, J.G. Latour, P. Joly, G. Levy, E. Pelletier, M. Juneau, J. Stasiak, P. deGuise Aspirin, heparin, or both to treat acute unstable angina N Engl J Med 319 1988 1105 1111
23. F. Colivicchi, V. Guido, M. Tubaro, F. Ammirati, N. Montefoschi, A. Varveri, M. Santini Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction Am J Cardiol 90 2002 872 874
24. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
25. Heart Protection Collaborative Study Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals a randomised placebo-controlled trial Lancet 360 2002 7 22
26. M.A. Meier, W.H. Al-Badr, J.V. Cooper, E.M. Kline-Rogers, D.E. Smith, K.A. Eagle, R.H. Mehta The new definition of myocardial infarction diagnostic and prognostic implications in patients with acute coronary syndromes Arch Intern Med 162 2002 1585 1589